SG/CALL/CVS HEALTH/100/0.1/20.09.24 Stock

Warrant

DE000SQ8Z7X2

Market Closed - Deutsche Boerse AG 15:36:04 2024-05-17 EDT
0.011 EUR -8.33% Intraday chart for SG/CALL/CVS HEALTH/100/0.1/20.09.24
Current month-57.69%
1 month-63.33%
Date Price Change
24-05-17 0.011 -8.33%
24-05-16 0.012 +33.33%
24-05-15 0.009 +12.50%
24-05-14 0.008 -38.46%
24-05-13 0.013 +8.33%

Delayed Quote Deutsche Boerse AG

Last update May 17, 2024 at 03:36 pm

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying CVS HEALTH CORPORATION
IssuerLogo Issuer Société Générale Société Générale
WKN SQ8Z7X
ISINDE000SQ8Z7X2
Date issued 2023-02-13
Strike 100 $
Maturity 2024-09-20 (124 Days)
Parity 10 : 1
Emission price 0.78
Emission volume N/A
Settlement Barausgleich
Currency EUR

Technical Indicators

Highest since issue 0.79
Lowest since issue 0.003
Spread 0.01
Spread %45.45%

Company Profile

CVS Health Corporation is one of the leading American suppliers of health products and services. Net sales (including intragroup) break down by activity as follows: - medical insurance plan management services (45.6%; Pharmacy Benefit Management): administrative management (reimbursement management, patient claim processing, etc.), drug distribution, decision-making information, sales of medical information management services, etc.; - retail distribution (28.5%): sale of prescription pharmaceutical products, OTC products, beauty and cosmetics products. At the end of 2023, products are marketed primarily via a network of more than 9,000 outlets and via the Internet. In addition, the group offers healthcare services through more than 1,000 clinics (MinuteClinic®); - medical benefits management (25.8%); - other (0.1%).
Sector
-
More about the company

Ratings for CVS Health Corporation

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: CVS Health Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
28
Last Close Price
57.68 USD
Average target price
71.37 USD
Spread / Average Target
+23.74%
Consensus
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW